Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Other Non-Current Assets (2016 - 2025)

AC Immune (ACIU) has disclosed Other Non-Current Assets for 10 consecutive years, with $730683.2 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 54.24% to $730683.2 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $730683.2 through Dec 2025, up 54.24% year-over-year, with the annual reading at $730683.2 for FY2025, 54.24% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $730683.2 at AC Immune, up from $473731.6 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $730683.2 in Q4 2025, with the low at $374725.9 in Q4 2022.
  • Average Other Non-Current Assets over 5 years is $475958.0, with a median of $406975.0 recorded in 2023.
  • The sharpest move saw Other Non-Current Assets fell 4.81% in 2022, then soared 54.24% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $393674.3 in 2021, then dropped by 4.81% to $374725.9 in 2022, then increased by 8.61% to $406975.0 in 2023, then rose by 16.4% to $473731.6 in 2024, then skyrocketed by 54.24% to $730683.2 in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $730683.2, $473731.6, and $406975.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.